Michael Becker to Rituximab
This is a "connection" page, showing publications Michael Becker has written about Rituximab.
Connection Strength
0.013
-
Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody. Biol Blood Marrow Transplant. 2003 Aug; 9(8):505-11.
Score: 0.013
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.